Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
Moodys
Mallinckrodt
Colorcon

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Dapivirine


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Dapivirine?

Dapivirine is an investigational drug.

There have been 41 clinical trials for Dapivirine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Infections. The leading clinical trial sponsors are International Partnership for Microbicides, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and National Institutes of Health (NIH).

There are three hundred and twenty-six US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Dapivirine
TitleSponsorPhase
Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant PairsNational Institute of Allergy and Infectious Diseases (NIAID)Phase 3
Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyNational Institute of Allergy and Infectious Diseases (NIAID)Phase 3
Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female PopulationNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2

See all Dapivirine clinical trials

Clinical Trial Summary for Dapivirine

Top disease conditions for Dapivirine
Top clinical trial sponsors for Dapivirine

See all Dapivirine clinical trials

US Patents for Dapivirine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dapivirine ⤷  Sign up for a Free Trial Use of solid carrier particles to improve the processability of a pharmaceutical agent Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign up for a Free Trial
Dapivirine ⤷  Sign up for a Free Trial Combination formulation of two antiviral compounds Gilead Pharmasset LLC (Foster City, CA) ⤷  Sign up for a Free Trial
Dapivirine ⤷  Sign up for a Free Trial Viral prophylaxis treatment methods and pre-exposure prophylaxis kits ELIAN LLC (Monrovia, CA) ⤷  Sign up for a Free Trial
Dapivirine ⤷  Sign up for a Free Trial Compounds and combinations for the treatment of HIV Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign up for a Free Trial
Dapivirine ⤷  Sign up for a Free Trial Substituted thiazoles as HIV integrase inhibitors Japan Tobacco Inc. (Tokyo, JP) ⤷  Sign up for a Free Trial
Dapivirine ⤷  Sign up for a Free Trial Therapeutic compounds Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dapivirine

Drugname Country Document Number Estimated Expiration Related US Patent
Dapivirine African Regional IP Organization (ARIPO) AP3089 2028-05-02 ⤷  Sign up for a Free Trial
Dapivirine African Regional IP Organization (ARIPO) AP3250 2028-05-02 ⤷  Sign up for a Free Trial
Dapivirine Argentina AR075369 2028-05-02 ⤷  Sign up for a Free Trial
Dapivirine Australia AU2009242451 2028-05-02 ⤷  Sign up for a Free Trial
Dapivirine Australia AU2010210598 2028-05-02 ⤷  Sign up for a Free Trial
Dapivirine Australia AU2014221210 2028-05-02 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
Moodys
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.